Oncology

Audio Journal of Oncology Volume 16 Number 8

Source: N Engl J Med 357:26, Annals of Oncology, April 9th, 2008

Scientific Editors: George Canellos, Pat Price, Gordon McVie, Gianni Bonadonna

In this edition:

Bevacizumab and Survival in Metastatic Breast Cancer

Source: N Engl J Med 357:26
George Canellos, Dana-Farber Cancer Institute, Boston
Progresson-free survival, but not overall survival, was extended in patients with metastatic breast cancer who were randomly assigned to receive paclitaxel with bevacizumab as compared with paclitaxel alone.

Risks From Stopping Cancer Trials Early

Source: Annals of Oncology, April 9th, 2008
Giovanni Apolone, Mario Negri Institute, Milan
Stuart Pocock, London School of Hygiene and Tropical Medicine
New research highlights the dangers of stopping cancer clinical trials early following interim analysis before originally planned sample sizes have been reached, especially when surrogate end points are used.

Download this interview

Similar Interviews

  • Hematologic Malignancy
  • Audio Journal of Hematologic Malignancy Volume 2 Number 1 Reporting from: American Society of Hematology Meeting, Philadelphia, December 6-10,

  • Audio Journal of Oncology Volume 16 Number 11
  • Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Sarah Maxwell and Peter Goodwin report from:

  • Audio Journal of Oncology Volume 16 Number 10
  • Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Commenting Expert: Michael Untch, HELIOS Klinikum, Berlin In

    Post a comment